Opus Genetics Slides Ahead of June Test
Opus Genetics shares fell 1.6% to $4.29 late Monday morning, retracing some of Friday’s gains. The company will present at the Jefferies Global Healthcare Conference in New York on June 3. Shares remain up over 100% for the year, though the company continues to post losses and awaits key clinical trial data. Trading volume reached about 288,500 shares, with a market cap near $373 million.